{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T20:44:50Z","timestamp":1783111490865,"version":"3.54.6"},"reference-count":18,"publisher":"American Association of Zoo Veterinarians","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Zoo and Wildlife Medicine"],"published-print":{"date-parts":[[2024,3,5]]},"DOI":"10.1638\/2023-0049","type":"journal-article","created":{"date-parts":[[2024,3,5]],"date-time":"2024-03-05T11:05:10Z","timestamp":1709636710000},"source":"Crossref","is-referenced-by-count":2,"title":["EFFICACY OF TOLAZOLINE AND VATINOXAN IN REDUCING ADVERSE EFFECTS OF BUTORPHANOL\u2013AZAPERONE\u2013MEDETOMIDINE IMMOBILIZATION IN ROCKY MOUNTAIN ELK (CERVUS CANADENSIS)"],"prefix":"10.1638","volume":"55","author":[{"given":"Annette","family":"Roug","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Nol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khursheed","family":"Mama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1213","reference":[{"key":"16","doi-asserted-by":"crossref","unstructured":"MH Vainionp\u00e4\u00e4, MR Raekallio, SA Pakkanen, et al.  \"Vet Anaesth Analg.\"  40, \"Plasma drug concentrations and clinical effects of a peripheral alpha-2-adrenoceptor antagonist, MK-467, in horses sedated with detomidine.\" 257 (2013)","DOI":"10.1111\/vaa.12012"},{"key":"18","doi-asserted-by":"crossref","unstructured":"LL Wolfe, MC Fisher, TR Davis, et al.  \"J Wildl Dis.\"  50, \"Efficacy of a low-dosage combination of butorphanol, azaperone, and medetomidine (BAM) to immobilize Rocky Mountain elk.\" 676 (2014)","DOI":"10.7589\/2014-02-026"},{"key":"10","doi-asserted-by":"crossref","unstructured":"BF Miller, DA Osborn, WR Lance, et al.  \"J Wildl Dis.\"  45, \"Butorphanol\u2013azaperone\u2013medetomidine for immobilization of captive white-tailed deer.\" 457 (2009)","DOI":"10.7589\/0090-3558-45.2.457"},{"key":"17","doi-asserted-by":"crossref","unstructured":"H. Wickham,  \"Elegant graphics for data analysis.\"  (2016)","DOI":"10.1007\/978-3-319-24277-4_9"},{"key":"8","unstructured":"TJ Kreeger  and JM Arnemo  \"Handbook of wildlife chemical immobilization.\"  (2018)"},{"key":"1","unstructured":"B Clineschmidt, DJ Pettibone, V Lotti, et al.  \"J Pharmacol Exp Ther.\"  245, \"A peripherally acting alpha-2 adrenoceptor antagonist: L-659,066.\" 32 (1998)"},{"key":"2","doi-asserted-by":"crossref","unstructured":"A de Vries, SA Pakkanen, MR Raekallio, et al.  \"Vet Anaesth Analg.\"  43, \"Clinical effects and pharmacokinetic variables of romifidine and the peripheral a2-adrenoceptor antagonist MK-467 in horses.\" 599 (2016)","DOI":"10.1111\/vaa.12354"},{"key":"3","doi-asserted-by":"crossref","unstructured":"J Einwaller, J Painer, M Raekallio, et al.  \"Vet Anaesth Analg.\"  47, \"Cardiovascular effects of intravenous vatinoxan (MK-467) in medetomidine\u2013tiletamine\u2013zolazepam anaesthetized red deer (Cervus elaphus).\" 518 (2020)","DOI":"10.1016\/j.vaa.2019.10.011"},{"key":"4","doi-asserted-by":"crossref","unstructured":"EM Greunz, D Lim\u00f3n, RL Petersen, et al.  \"Vet Anaesth Analg.\"  48, \"The impact of vatinoxan on medetomidine\u2013ketamine\u2013midazolam immobilization in Patagonian maras (Dolichotis patagonum).\" 372 (2021)","DOI":"10.1016\/j.vaa.2020.08.012"},{"key":"5","doi-asserted-by":"crossref","unstructured":"RC Hector, KR Mama, MC Fisher, et al.  \"J Zoo Wildl Med.\"  51, \"Evaluation of two medetomidine\u2013azaperone\u2013alfaxalone combinations in captive rocky mountain elk (Cervus elaphus nelsoni).\" 825 (2021)","DOI":"10.1638\/2020-0028"},{"key":"6","doi-asserted-by":"crossref","unstructured":"JM Honkavaara, F Restitutti, MR Raekallio, et al.  \"J Vet Pharmacol Ther.\"  34, \"The effects of increasing doses of MK-467, a peripheral alpha2-adrenergic receptor antagonist, on the cardiopulmonary effects of intravenous dexmedetomidine in conscious dogs.\" 332 (2011)","DOI":"10.1111\/j.1365-2885.2010.01242.x"},{"key":"7","unstructured":"A. Kassambara,  \"Pipe-friendly framework for basic statistical tests. R package version 0.7.0.\"  (2021)"},{"key":"9","doi-asserted-by":"crossref","unstructured":"PM Mich, LL Wolfe, TM Sirochman, et al.  \"J Zoo Wildl Med.\"  39, \"Evaluation of intramuscular butorphanol, azaperone, and medetomidine and nasal oxygen insufflation for the chemical immobilization of white-tailed deer (Odocoileus virginianus).\" 480 (2008)","DOI":"10.1638\/2007-0150.1"},{"key":"11","unstructured":"LP. Posner,  \"Veterinary pharmacology and therapeutics.\"  \"Chapter 14. Sedatives and tranquilizers.\" 324 (2018)"},{"key":"12","doi-asserted-by":"crossref","unstructured":"M Raekallio, J Honkavaara, O Vainio,  \"J Vet Pharmacol Ther.\"  33, \"The effects of L-659,066, a peripheral a2-adrenoceptor antagonist, and verapamil on the cardiovascular influences of dexmedetomidine in conscious sheep.\" 434 (2010)","DOI":"10.1111\/j.1365-2885.2009.01156.x"},{"key":"13","doi-asserted-by":"crossref","unstructured":"F Restitutti, JM Honkavaara, MR Raekallio, et al.  \"Vet Anaesth Analg.\"  38, \"Effects of different doses of L-659'066 on the bispectral index and clinical sedation in dogs treated with dexmedetomidine.\" 415 (2011)","DOI":"10.1111\/j.1467-2995.2011.00630.x"},{"key":"14","doi-asserted-by":"crossref","unstructured":"S Sainmaa, A Mykk\u00e4nen, M Adam, et al.  \"J Zoo Wildl Med.\"  50, \"Intravenous vatinoxan in markhors (Capra falconeri heptneri) immobilized with intramuscular medetomidine and ketamine\u2014a preliminary dosescreening study.\" 159 (2019)","DOI":"10.1638\/2018-0030"},{"key":"15","doi-asserted-by":"crossref","unstructured":"DD Schwartz  and TP Clark  \"J Vet Pharmacol Ther.\"  21, \"Selectivity of atipamezole, yohimbine and tolazoline for alpha-2 adrenergic receptor subtypes: implications for clinical reversal of alpha-2 adrenergic receptor mediated sedation in sheep.\" 342 (1998)","DOI":"10.1046\/j.1365-2885.1998.00151.x"}],"container-title":["Journal of Zoo and Wildlife Medicine"],"original-title":[],"deposited":{"date-parts":[[2024,3,5]],"date-time":"2024-03-05T11:05:20Z","timestamp":1709636720000},"score":1,"resource":{"primary":{"URL":"https:\/\/bioone.org\/journals\/journal-of-zoo-and-wildlife-medicine\/volume-55\/issue-1\/2023-0049\/EFFICACY-OF-TOLAZOLINE-AND-VATINOXAN-IN-REDUCING-ADVERSE-EFFECTS-OF\/10.1638\/2023-0049.full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,5]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,3,1]]}},"URL":"https:\/\/doi.org\/10.1638\/2023-0049","relation":{},"ISSN":["1042-7260"],"issn-type":[{"value":"1042-7260","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3,5]]}}}